Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

US Department of Veterans Affairs (VA)

Status and phase: Completed; Phase 2

Conditions: Alzheimer's Disease

Treatments: Drug: estrogen

Study type: Interventional

Funder types: Other U.S. Federal agency

Identifiers

NCT00018343

AGCG-007-97F

Details and patient eligibility

About

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Sex: Female

Ages: 50 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Post menopausal women with alzheimer's disease
• free of any major medical or neurological disease,
• medically safe to be treated with estrogen.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind